» Articles » PMID: 29207008

Cannabis Use and Hypomania in Young People: A Prospective Analysis

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2017 Dec 6
PMID 29207008
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cannabis use in young people is common and associated with psychiatric disorders. However, the prospective link between cannabis use and bipolar disorder symptoms has rarely been investigated. The study hypothesis was that adolescent cannabis use is associated with hypomania in early adulthood via several potential etiological pathways.

Methods: Data were used from the Avon Longitudinal Study of Parents and Children, a UK birth cohort study. The prospective link between cannabis use at age 17 and hypomania at age 22-23 years was tested using regression analysis, adjusted for gender, early environmental risk factors, alcohol and drug use, and depression and psychotic symptoms at age 18 years. Path analysis examined direct and indirect effects of the link and whether gender, childhood family adversity, or childhood abuse are associated with hypomania via an increased risk of cannabis use.

Results: Data were available on 3370 participants. Cannabis use at least 2-3 times weekly was associated with later hypomania (OR = 2.21, 95% CI = 1.49-3.28) after adjustment. There was a dose-response relationship (any use vs weekly). Cannabis use mediated the association of both childhood sexual abuse and hypomania, and male gender and hypomania. The cannabis use-hypomania link was not mediated by depression or psychotic symptoms.

Conclusions: Adolescent cannabis use may be an independent risk factor for future hypomania, and the nature of the association suggests a potential causal link. Cannabis use mediates the link between childhood abuse and future hypomania. As such it might be a useful target for indicated prevention of hypomania.

Citing Articles

ADHD symptom trajectories across childhood and early adolescence and risk for hypomanic symptoms in young adulthood.

Durdurak B, Morales Munoz I, Morales-Munoz I, Hosang G, Marwaha S Eur Psychiatry. 2025; 68(1):e37.

PMID: 39967022 PMC: 11883789. DOI: 10.1192/j.eurpsy.2025.24.


Comprehensive bibliometric analysis of pharmacotherapy for bipolar disorders: Present trends and future directions.

Chen B, Liu L, Lin F, Zeng H, Huang H, Zhang C World J Psychiatry. 2025; 15(1):100685.

PMID: 39831017 PMC: 11684214. DOI: 10.5498/wjp.v15.i1.100685.


Hypomania-Checklist-33: risk stratification and factor structure in a mixed psychiatric adolescent sample.

Gerstenberg M, Smigielski L, Werling A, Dimitriades M, Correll C, Walitza S Int J Bipolar Disord. 2024; 12(1):28.

PMID: 39112720 PMC: 11306698. DOI: 10.1186/s40345-024-00350-x.


Cannabis use and mood disorders: a systematic review.

Sorkhou M, Dent E, George T Front Public Health. 2024; 12:1346207.

PMID: 38655516 PMC: 11035759. DOI: 10.3389/fpubh.2024.1346207.


Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models.

Perrottelli A, Marzocchi F, Caporusso E, Giordano G, Giuliani L, Melillo A J Psychiatry Neurosci. 2024; 49(2):E109-E125.

PMID: 38490647 PMC: 10950363. DOI: 10.1503/jpn.230112.


References
1.
Marwaha S, Gordon-Smith K, Broome M, Briley P, Perry A, Forty L . Affective instability, childhood trauma and major affective disorders. J Affect Disord. 2015; 190:764-771. DOI: 10.1016/j.jad.2015.11.024. View

2.
DSouza D, Abi-Saab W, Madonick S, Forselius-Bielen K, Doersch A, Braley G . Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry. 2005; 57(6):594-608. DOI: 10.1016/j.biopsych.2004.12.006. View

3.
Boyd A, Golding J, Macleod J, Lawlor D, Fraser A, Henderson J . Cohort Profile: the 'children of the 90s'--the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2012; 42(1):111-27. PMC: 3600618. DOI: 10.1093/ije/dys064. View

4.
Henquet C, Krabbendam L, de Graaf R, Have M, van Os J . Cannabis use and expression of mania in the general population. J Affect Disord. 2006; 95(1-3):103-10. DOI: 10.1016/j.jad.2006.05.002. View

5.
Zammit S, Kounali D, Cannon M, David A, Gunnell D, Heron J . Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry. 2013; 170(7):742-50. DOI: 10.1176/appi.ajp.2013.12060768. View